Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Vaccine Adjuvants Market to reach USD 1.94 billion by the end of 2030

Global Vaccine Adjuvants Market Size study & Forecast, by Type (Pathogen, Adjuvant emulsion, Particulate, Combination, Others), by Application (Infectious diseases, Cancer, Others), by Administration (Oral, Intradermal, Intranasal, Intramuscular, Others) and Regional Analysis, 2023-2030

Product Code: HLSDT-41292380
Publish Date: 20-02-2024
Page: 200

Global Vaccine Adjuvants Market is valued at approximately USD 1.62 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 2.3% during the forecast period 2023-2030.Adjuvants are the ingredients that are added to the vaccinations to increase effectiveness of the vaccine and improve its response. The expansion of the Vaccine Adjuvants Market is due to factors such as the increasing incidence of infectious diseases, growing geriatric population and rising awareness towards health and immunization.

The awareness towards vaccination and immunization regarding the prevention of infectious diseases such as HIV and tuberculosis (TB) has gradually increased over a period of time. according to Centers for Disease Control and Prevention, there were 39 million people in the world who were suffering with HIV and this number is expected to reduce by 2% due to rising number of vaccine prevalence. Furthermore, according to World Health Organization, approximately 10.6 million people suffered with Tuberculosis (TB) around the globe. The continuous increase in the number of patients of infectious diseases lead to the rise in health awareness campaigns and immunization programs to reduce the number by using the preventive measures. Moreover, rising healthcare facilities and advancements in formulations are the opportunities through which the Vaccine Adjuvants Market can grow. However, the high cost of production of development may hinder the expansion of the Vaccine Adjuvants Market throughout the forecast period of 2020-2030.

The key regions considered for the Global Vaccine Adjuvants Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 due to factors such as an increase in investments in R&D and a rise in severe diseases. Consequently, vaccination against both acute and chronic diseases become necessary. Middle East & Africa are expected to grow significantly over the forecast period due to factors such as constantly enhancing medical facilities, which include the availability of medications and increasing financing for research and development to meet the massive unfulfilled needs. This is projected to raise the market share of Vaccine Adjuvants in the particular region.
Major market player included in this report are:
GlaxoSmithKline plc.
Novavax, Inc.
Adjuvance Technologies, Inc.
SPI Pharma
Agenus, Inc.
CSL Limited
InvivoGen
AstrazenecaCroda International Plc
Pfizer Inc.

Recent Developments in the Market:
Ø In May 2023, GSK plc declared that the US Food and Drug Administration approved Arexvy for the treatment of Respiratory Syncytial Virus (RSV) -related Lower Respiratory Tract Disease (LRTD) in patients 60 years of age and older. This is the first ever RSV immunization which is licensed for older people worldwide.
Ø In March 2022, Croda International Plc confirmed the partnership with Statens Serum Institute. They mayproduce and commercialise a variety of patented cationic adjuvants, CAF which was developed by SSI.

Global Vaccine Adjuvants Market Report Scope:
ü Historical Data –2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Type, Application, Administration, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporatespotential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Pathogen
Adjuvant emulsion
Particulate
Combination
Others

By Application:
Infectious diseases
Cancer
Others

By Administration:
Oral
Intradermal
Intranasal
Intramuscular
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Vaccine Adjuvants Market, by Region, 2020-2030 (USD Billion)
1.2.2. Vaccine Adjuvants Market, by Type,2020-2030 (USD Billion)
1.2.3. Vaccine Adjuvants Market, by Application , 2020-2030 (USD Billion)
1.2.4. Vaccine Adjuvants Market, by Administration, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Vaccine Adjuvants Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Vaccine Adjuvants Market Dynamics
3.1. Vaccine Adjuvants Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of chronic diseases
3.1.1.2. Growing Geriatric Population
3.1.1.3. Rising awareness towards immunization
3.1.1.4.
3.1.2. Market Challenges
3.1.2.1. High Cost of Vaccine Adjuvants
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation
3.1.3.2. Rising Healthcare Facilities
Chapter 4. Global Vaccine Adjuvants MarketIndustry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Vaccine Adjuvants Market, by Type
5.1. Market Snapshot
5.2. Global Vaccine Adjuvants Market by Type, Performance – Potential Analysis
5.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Type2020-2030 (USD Billion)
5.4. Vaccine Adjuvants Market, Sub Segment Analysis
5.4.1. Pathogen
5.4.2. Adjuvant emulsion
5.4.3. Particulate
5.4.4. Combination
5.4.5. Others
Chapter 6. Global Vaccine Adjuvants Market, by Application
6.1. Market Snapshot
6.2. Global Vaccine Adjuvants Market by Application , Performance – Potential Analysis
6.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Vaccine Adjuvants Market, Sub Segment Analysis
6.4.1. Infectious diseases
6.4.2. Cancer
6.4.3. Others
Chapter 7. Global Vaccine Adjuvants Market, byAdministration
7.1. Market Snapshot
7.2. Global Vaccine Adjuvants Market by Administration, Performance – Potential Analysis
7.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Administraion2020-2030 (USD Billion)
7.4. Vaccine Adjuvants Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Intradermal
7.4.3. Intranasal
7.4.4. Intramuscular
7.4.5. Others
Chapter 8. Global Vaccine Adjuvants Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Vaccine Adjuvants Market, Regional Market Snapshot
8.4. North America Vaccine Adjuvants Market
8.4.1. U.S.Vaccine Adjuvants Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. Administration breakdown estimates & forecasts, 2020-2030
8.4.2. CanadaVaccine Adjuvants Market
8.5. Europe Vaccine Adjuvants Market Snapshot
8.5.1. U.K. Vaccine Adjuvants Market
8.5.2. Germany Vaccine Adjuvants Market
8.5.3. France Vaccine Adjuvants Market
8.5.4. Spain Vaccine Adjuvants Market
8.5.5. Italy Vaccine Adjuvants Market
8.5.6. Rest of EuropeVaccine Adjuvants Market
8.6. Asia-PacificVaccine Adjuvants Market Snapshot
8.6.1. China Vaccine Adjuvants Market
8.6.2. India Vaccine Adjuvants Market
8.6.3. JapanVaccine Adjuvants Market
8.6.4. Australia Vaccine Adjuvants Market
8.6.5. South Korea Vaccine Adjuvants Market
8.6.6. Rest of Asia PacificVaccine Adjuvants Market
8.7. Latin America Vaccine Adjuvants Market Snapshot
8.7.1. Brazil Vaccine Adjuvants Market
8.7.2. MexicoVaccine Adjuvants Market
8.8. Middle East & AfricaVaccine Adjuvants Market
8.8.1. Saudi ArabiaVaccine Adjuvants Market
8.8.2. South AfricaVaccine Adjuvants Market
8.8.3. Rest of Middle East & AfricaVaccine Adjuvants Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. GlaxoSmithKline plc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. ProductSummary
9.3.1.5. Recent Developments
9.3.2. Novavax, Inc.
9.3.3. Adjuvance Technologies, Inc.
9.3.4. SPI Pharma
9.3.5. Agenus, Inc.
9.3.6. CSL Limited
9.3.7. InvivoGen
9.3.8. AstrazenecaCroda
9.3.9. International Plc
9.3.10. Pfizer Inc
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now